[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q3_USD":8908000.0,"OtherAssetsCurrent_0_Q3_USD":6635000.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_3_Q3_USD":1895000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":27264000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":2800000.0,"OperatingIncomeLoss_3_Q3_USD":122860000.0,"OperatingIncomeLoss_1_Q3_USD":-28096000.0,"OperatingExpenses_3_Q3_USD":113012000.0,"OperatingExpenses_1_Q3_USD":33604000.0,"NonoperatingIncomeExpense_3_Q3_USD":11579000.0,"NonoperatingIncomeExpense_1_Q3_USD":3124000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_3_Q3_USD":93516000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q3_USD":-21380000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":93516000.0,"OtherAssetsNoncurrent_0_Q3_USD":31616000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":-21380000.0,"NetIncomeLoss_1_Q3_USD":-21380000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":261296000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-331098000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":-5720000.0,"LiabilitiesNoncurrent_0_Q3_USD":169786000.0,"LiabilitiesCurrent_0_Q3_USD":49549000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":1172732000.0,"Liabilities_0_Q3_USD":219335000.0,"InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_0_Q3_USD":47507000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q3_USD":148821000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3_Q3_shares":49680511.0,"IncreaseDecreaseInRoyaltiesPayable_3_Q3_USD":-26548000.0,"IncreaseDecreaseInReceivables_3_Q3_USD":34329000.0,"NetIncomeLoss_3_Q3_USD":93516000.0,"IncreaseDecreaseInOtherOperatingAssets_3_Q3_USD":3458000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":-1508000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":1695000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":323323053.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":278933760.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":899000.0,"StockholdersEquity_0_Q3_USD":953397000.0,"ShareBasedCompensation_3_Q3_USD":21608000.0,"SellingAndMarketingExpense_3_Q3_USD":5086000.0,"SellingAndMarketingExpense_1_Q3_USD":1217000.0,"RoyaltyExpense_3_Q3_USD":23622000.0,"RoyaltyExpense_1_Q3_USD":0.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":235872000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":5508000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":207720000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":44853000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":644000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":17450000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":91584000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":100089000.0,"ProfitLoss_3_Q3_USD":93516000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":2781000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_3_Q3_USD":9527000.0,"ProceedsFromIssuanceOfLongTermDebt_3_Q3_USD":872000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":49022000.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":245314000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_3_Q3_USD":11457000.0,"PaymentForContingentConsiderationLiabilityFinancingActivities_3_Q3_USD":2550000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-595000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-1256000.0,"OtherNoncashIncomeExpense_3_Q3_USD":-888000.0,"RepaymentsOfLongTermDebt_3_Q3_USD":1823000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":278933760.0,"IncreaseDecreaseInDeferredRevenue_3_Q3_USD":9051000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":40923000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":94160000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-22888000.0,"CommonStockValue_0_Q3_USD":718088000.0,"CommonStockSharesOutstanding_0_Q3_shares":281151877.0,"CommonStockSharesIssued_0_Q3_shares":281151877.0,"CommonStockNoParValue_0_Q3_USD":null,"CommitmentsAndContingencies_0_Q3_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-76422000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":517694000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":517694000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q3_USD":44948000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q3_USD":12122000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":235785000.0,"ContractWithCustomerLiability_0_Q3_USD":35350000.0,"AssetsNoncurrent_0_Q3_USD":368985000.0,"Assets_0_Q3_USD":1172732000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":44848480.0,"AmortizationOfIntangibleAssets_3_Q3_USD":7432000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":21608000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":7707000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":7707000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":26945000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":644000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":8505000.0,"AccruedRoyaltiesCurrent_0_Q3_USD":595000.0,"AccruedIncomeTaxesCurrent_0_Q3_USD":6590000.0,"AccountsPayableAndOtherAccruedLiabilitiesCurrent_0_Q3_USD":24072000.0,"AccountsPayableAndOtherAccruedLiabilities_0_Q3_USD":24072000.0,"AssetsCurrent_0_Q3_USD":803747000.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_3_Q3_USD":-29563000.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":6170000.0,"ContractWithCustomerLiabilityRevenueRecognized_3_Q3_USD":2300000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":-3592000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":134439000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-24972000.0,"Goodwill_0_Q3_USD":49457000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":28958000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":11271000.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":35539000.0,"FiniteLivedIntangibleAssetsGross_0_Q3_USD":158773000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q3_USD":7087000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q3_USD":3921000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q3_USD":3921000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q3_USD":10305000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q3_USD":10305000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q3_USD":1500000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q3_USD":9952000.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q3_USD":0.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":3617000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":-900000.0,"EarningsPerShareDiluted_3_Q3_USD":0.29,"EarningsPerShareDiluted_1_Q3_USD":-0.08,"EarningsPerShareBasic_3_Q3_USD":0.34,"EarningsPerShareBasic_1_Q3_USD":-0.08,"DepreciationAndAmortization_3_Q3_USD":10493000.0,"DepreciationAndAmortization_1_Q3_USD":3666000.0,"Depreciation_3_Q3_USD":3060000.0,"Depreciation_1_Q3_USD":1200000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q3_USD":36197000.0,"DeferredIncomeTaxExpenseBenefit_3_Q3_USD":-3267000.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q3_USD":0.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":273642542.0,"Ticker":"ABCL","CIK":"1703057","name":"ABCELLERA BIOLOGICS INC.","OfficialName":"AbCellera Biologics Inc. Common Shares","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2455839092.0","Country":"Canada","Sector":"nan","Industry":"nan","Market":"NASDAQ","SP500":"nan","filed":"20211110"}]